CN100536799C - 动物组织生长诱导支架 - Google Patents
动物组织生长诱导支架 Download PDFInfo
- Publication number
- CN100536799C CN100536799C CNB2003101034628A CN200310103462A CN100536799C CN 100536799 C CN100536799 C CN 100536799C CN B2003101034628 A CNB2003101034628 A CN B2003101034628A CN 200310103462 A CN200310103462 A CN 200310103462A CN 100536799 C CN100536799 C CN 100536799C
- Authority
- CN
- China
- Prior art keywords
- animal tissue
- growth inducing
- inducing support
- support
- district
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 241001465754 Metazoa Species 0.000 title claims abstract description 34
- 230000012010 growth Effects 0.000 title claims abstract description 32
- 230000001939 inductive effect Effects 0.000 title claims abstract description 26
- 230000008093 supporting effect Effects 0.000 claims abstract description 37
- 239000000463 material Substances 0.000 claims abstract description 35
- 239000000560 biocompatible material Substances 0.000 claims abstract description 3
- 239000010410 layer Substances 0.000 claims description 44
- 239000012790 adhesive layer Substances 0.000 claims description 39
- 230000008467 tissue growth Effects 0.000 claims description 33
- 239000000565 sealant Substances 0.000 claims description 31
- WHBMMWSBFZVSSR-UHFFFAOYSA-N 3-hydroxybutyric acid Chemical compound CC(O)CC(O)=O WHBMMWSBFZVSSR-UHFFFAOYSA-N 0.000 claims description 20
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 18
- 230000015556 catabolic process Effects 0.000 claims description 17
- 238000006731 degradation reaction Methods 0.000 claims description 17
- 229920001577 copolymer Polymers 0.000 claims description 12
- 229960000448 lactic acid Drugs 0.000 claims description 10
- 238000007334 copolymerization reaction Methods 0.000 claims description 9
- 229910052751 metal Inorganic materials 0.000 claims description 9
- 239000002184 metal Substances 0.000 claims description 9
- 230000000694 effects Effects 0.000 claims description 7
- 229920001610 polycaprolactone Polymers 0.000 claims description 7
- 239000004632 polycaprolactone Substances 0.000 claims description 7
- 235000014655 lactic acid Nutrition 0.000 claims description 6
- 239000004310 lactic acid Substances 0.000 claims description 6
- 229920000570 polyether Polymers 0.000 claims description 6
- JVTAAEKCZFNVCJ-REOHCLBHSA-N L-lactic acid Chemical compound C[C@H](O)C(O)=O JVTAAEKCZFNVCJ-REOHCLBHSA-N 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 claims description 4
- 239000004721 Polyphenylene oxide Substances 0.000 claims description 4
- 229910001069 Ti alloy Inorganic materials 0.000 claims description 4
- 238000009954 braiding Methods 0.000 claims description 4
- 238000009740 moulding (composite fabrication) Methods 0.000 claims description 4
- 229920000747 poly(lactic acid) Polymers 0.000 claims description 4
- 239000004626 polylactic acid Substances 0.000 claims description 4
- 229920001897 terpolymer Polymers 0.000 claims description 4
- PAPBSGBWRJIAAV-UHFFFAOYSA-N ε-Caprolactone Chemical compound O=C1CCCCCO1 PAPBSGBWRJIAAV-UHFFFAOYSA-N 0.000 claims description 4
- 229920000954 Polyglycolide Polymers 0.000 claims description 3
- 238000002955 isolation Methods 0.000 claims description 3
- 239000003550 marker Substances 0.000 claims description 3
- 230000000149 penetrating effect Effects 0.000 claims description 3
- 229920001432 poly(L-lactide) Polymers 0.000 claims description 3
- 239000004633 polyglycolic acid Substances 0.000 claims description 3
- 229920001400 block copolymer Polymers 0.000 claims description 2
- 210000000056 organ Anatomy 0.000 abstract description 38
- 238000007789 sealing Methods 0.000 abstract description 3
- 230000001172 regenerating effect Effects 0.000 abstract 1
- 230000006698 induction Effects 0.000 description 28
- 210000003238 esophagus Anatomy 0.000 description 24
- 210000001519 tissue Anatomy 0.000 description 21
- 238000000034 method Methods 0.000 description 17
- 210000003437 trachea Anatomy 0.000 description 12
- 238000005516 engineering process Methods 0.000 description 11
- 210000004027 cell Anatomy 0.000 description 9
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- 210000000988 bone and bone Anatomy 0.000 description 5
- 241000282472 Canis lupus familiaris Species 0.000 description 4
- 210000000981 epithelium Anatomy 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 3
- 229920001519 homopolymer Polymers 0.000 description 3
- 238000001746 injection moulding Methods 0.000 description 3
- 238000003825 pressing Methods 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- -1 and wherein Substances 0.000 description 2
- 210000001557 animal structure Anatomy 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 238000005266 casting Methods 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 239000010408 film Substances 0.000 description 2
- 238000007731 hot pressing Methods 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 210000004379 membrane Anatomy 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000002787 reinforcement Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 239000010409 thin film Substances 0.000 description 2
- 210000000115 thoracic cavity Anatomy 0.000 description 2
- 238000002054 transplantation Methods 0.000 description 2
- 238000003466 welding Methods 0.000 description 2
- 208000017897 Carcinoma of esophagus Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 1
- 229930012538 Paclitaxel Natural products 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 102000013275 Somatomedins Human genes 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 210000000013 bile duct Anatomy 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000746 body region Anatomy 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000002498 deadly effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 210000005081 epithelial layer Anatomy 0.000 description 1
- 201000005619 esophageal carcinoma Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 230000001861 immunosuppressant effect Effects 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 229910001092 metal group alloy Inorganic materials 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 210000003101 oviduct Anatomy 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 229960001592 paclitaxel Drugs 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 description 1
- 229920001281 polyalkylene Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000000626 ureter Anatomy 0.000 description 1
- 210000003556 vascular endothelial cell Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Landscapes
- Prostheses (AREA)
Abstract
Description
Claims (18)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2003101034628A CN100536799C (zh) | 2003-11-03 | 2003-11-03 | 动物组织生长诱导支架 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2003101034628A CN100536799C (zh) | 2003-11-03 | 2003-11-03 | 动物组织生长诱导支架 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1613434A CN1613434A (zh) | 2005-05-11 |
CN100536799C true CN100536799C (zh) | 2009-09-09 |
Family
ID=34756679
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2003101034628A Expired - Fee Related CN100536799C (zh) | 2003-11-03 | 2003-11-03 | 动物组织生长诱导支架 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100536799C (zh) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9707070B2 (en) * | 2014-07-07 | 2017-07-18 | Cook Medical Technologies Llc | Migration-resistant gastrointestinal barrier |
CN104207807A (zh) * | 2014-09-04 | 2014-12-17 | 中国人民解放军兰州军区兰州总医院 | 可吸收颅骨成型修补三维聚左旋丙交酯乳酸网 |
CN104225678B (zh) * | 2014-09-30 | 2016-05-11 | 广西中医药大学 | 一种医用钛金属材料及其制备方法 |
US10265153B2 (en) * | 2015-11-12 | 2019-04-23 | Biostage, Inc. | Systems and methods for producing gastrointestinal tissues |
CN106963515B (zh) * | 2017-02-24 | 2018-12-18 | 上海长海医院 | 一种主动脉覆膜支架 |
CN107115165A (zh) * | 2017-05-11 | 2017-09-01 | 常州大学 | 一种加筋硅酮气道支架的制备技术 |
CN107095728A (zh) * | 2017-05-19 | 2017-08-29 | 东莞颠覆产品设计有限公司 | 管腔内载药支架 |
CN110192932B (zh) * | 2019-06-06 | 2023-07-21 | 苏州晶俊新材料科技有限公司 | 一种用于直肠吻合口保护的可降解肠道支架 |
CN111803713A (zh) * | 2020-05-29 | 2020-10-23 | 广州新诚生物科技有限公司 | 一种编织膜、编织袋及编织方法 |
-
2003
- 2003-11-03 CN CNB2003101034628A patent/CN100536799C/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN1613434A (zh) | 2005-05-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Palminteri et al. | Small intestinal submucosa (SIS) graft urethroplasty: short-term results | |
Lv et al. | A smart bilayered scaffold supporting keratinocytes and muscle cells in micro/nano-scale for urethral reconstruction | |
Gasior et al. | A review of patch options in the repair of congenital diaphragm defects | |
CN103025361B (zh) | 平滑肌细胞结构 | |
US11058534B2 (en) | Tubular prostheses | |
Rashidbenam et al. | Overview of urethral reconstruction by tissue engineering: current strategies, clinical status and future direction | |
US20110035023A1 (en) | Prosthesis for promoting the in vivo reconstruction of a hollow organ or a portion of a hollow organ | |
US8758447B2 (en) | Device and method for repair of urological structures | |
CN100536799C (zh) | 动物组织生长诱导支架 | |
Sharma et al. | Biomaterials assisted reconstructive urology: The pursuit of an implantable bioengineered neo-urinary bladder | |
CN102895702B (zh) | 一种复合人工胆管及其制备方法 | |
Pribitkin et al. | Rabbit ear cartilage regeneration with a small intestinal submucosa graft | |
Soltysiak et al. | Comparison of suturing techniques in the formation of collagen scaffold tubes for composite tubular organ tissue engineering | |
CN204219093U (zh) | 一种可降解球形人工膀胱 | |
SK13892003A3 (sk) | Spôsob autológnej transplantácie | |
JP2001340446A (ja) | 人工消化管 | |
WO1991008718A1 (en) | Hollow viscus prosthesis and method of implantation | |
Ha et al. | Urethra | |
Sloff | From urological tissue engineering to conduit innovations | |
Marcovich | APPROACHES TO TISSUE ENGINEERING IN THE URINARY TRACT. | |
Terlecki et al. | Tissue Engineering of the Urethra: The Basics, Current Concept, and the Future | |
WO2003075974A1 (fr) | Tube digestif artificiel | |
CN104188734A (zh) | 一种可降解球形人工膀胱 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee | ||
CP03 | Change of name, title or address |
Address after: Beijing City, Chaoyang District Jiuxianqiao Road No. 2 Gongmei Building Room 305 Patentee after: TransEasy Medical Tech. Co.,Ltd. Address before: Beijing City, Chaoyang District Jiuxianqiao Road No. 2 Gongmei Building Room 305 Patentee before: Beijing TransEasy Medical Tech. Co., Ltd. |
|
C56 | Change in the name or address of the patentee | ||
CP02 | Change in the address of a patent holder |
Address after: 101102 Beijing City, Tongzhou District Majuqiao town Jing Sheng 4 South Street No. 13 (East U Valley East) 3F floor 2 Patentee after: TransEasy Medical Tech. Co.,Ltd. Address before: 100015 Beijing City, Chaoyang District Jiuxianqiao Road No. 2 Gongmei Building Room 305 Patentee before: TransEasy Medical Tech. Co.,Ltd. |
|
DD01 | Delivery of document by public notice |
Addressee: TransEasy Medical Tech. Co.,Ltd. Document name: Notification of Passing Examination on Formalities |
|
DD01 | Delivery of document by public notice |
Addressee: Beijing transeasy medical technology Limited by Share Ltd Intellectual Property Department Document name: Notification to Pay the Fees |
|
DD01 | Delivery of document by public notice |
Addressee: Xu Songling Document name: Notification to Pay the Fees |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090909 Termination date: 20161103 |